Journal of Neural Transmission 2003-11-01

The interaction of tetrahydroisoquinoline derivatives with antinociceptive action of morphine and oxotremorine in mice.

J Vetulani, F Pavone, B Przewłocka, V Borghi, I Nalepa

Index: J. Neural Transm. Gen. Sect. 110(11) , 1205-13, (2003)

Full Text: HTML

Abstract

To extend our earlier data on synergistic action of tetrahydroisoquinolines and morphine, we have investigated the analgesic effects of 1,2,3,4-tetrahydroisoquinoline (TIQ) and its 1-methyl-(1-MeTIQ) and N-methyl (N-MeTIQ) analogs on analgesia induced by morphine and oxotremorine. 1-MeTIQ and N-MeTIQ induced a moderate, delayed and prolonged analgesic action measured in the tail-flick test in CD-1 mice; 1-MeTIQ and TIQ prolonged the opiate (morphine, 2.5 mg/kg i.p.) analgesia while TIQ and N-TIQ potentiated cholinergic (oxotremorine, 0.02 mg/kg i.p.) analgesia. The involvement of the opioid and noradrenergic systems in this effect is discussed.

Related Compounds

  • 1-Methyl-1,2,3,4-t...

Related Articles:

Comparative behavioral and neurochemical studies of R- and S-1-methyl-1,2,3,4-tetrahydroisoquinoline stereoisomers in the rat.

2012-01-01

[Pharmacol. Rep. 64(4) , 857-69, (2012)]

Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study.

2010-01-01

[Pharmacol. Rep. 62(6) , 983-97, (2010)]

Determination method of 1-methyl-1,2,3, 4-tetrahydroisoquinoline, an endogenous parkinsonism-preventing substance, by radioimmunoassay.

2002-05-03

[Life Sci. 70(24) , 2871-83, (2002)]

Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: A type I isobolographic analysis

2010-01-01

[Epilepsy Res. 89(2-3) , 207-19, (2010)]

A synthesis of heteroaromatic analogues of 1-methyl-1,2,3,4-tetrahydroisoquinoline using the Pummerer-type cyclization reaction: observation of tandem cyclization reaction.

2004-02-01

[Chem. Pharm. Bull. 52(2) , 214-20, (2004)]

More Articles...